205178-80-9 Usage
Description
2-Bromo-1-(4-chloro-3-methylphenyl)ethan-1-one, with the molecular formula C9H9BrOCl, is an organic compound belonging to the class of aryl alkyl ketones. It is recognized for its diverse biological activities, such as antifungal, antibacterial, and antiparasitic properties, and is commonly utilized as a building block in the synthesis of pharmaceuticals and agrochemicals.
Uses
Used in Pharmaceutical Industry:
2-Bromo-1-(4-chloro-3-methylphenyl)ethan-1-one is used as a building block for the synthesis of various pharmaceuticals due to its diverse biological activities, including antifungal, antibacterial, and antiparasitic properties. Its unique structure allows for the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical industry, 2-Bromo-1-(4-chloro-3-methylphenyl)ethan-1-one is used as an intermediate in the production of various agrochemicals. Its biological activities make it a valuable component in the development of pesticides and other agricultural chemicals to protect crops and enhance yield.
It is crucial to handle 2-Bromo-1-(4-chloro-3-methylphenyl)ethan-1-one with care, as it can pose health and environmental risks if not properly managed.
Check Digit Verification of cas no
The CAS Registry Mumber 205178-80-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,5,1,7 and 8 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 205178-80:
(8*2)+(7*0)+(6*5)+(5*1)+(4*7)+(3*8)+(2*8)+(1*0)=119
119 % 10 = 9
So 205178-80-9 is a valid CAS Registry Number.
InChI:InChI=1/C9H8BrClO/c1-6-4-7(9(12)5-10)2-3-8(6)11/h2-4H,5H2,1H3
205178-80-9Relevant articles and documents
New pyridazinone-4-carboxamides as new cannabinoid receptor type-2 inverse agonists: Synthesis, pharmacological data and molecular docking
Ragusa, Giulio,Gómez-Ca?as, María,Morales, Paula,Rodríguez-Cueto, Carmen,Pazos, María R.,Asproni, Battistina,Cichero, Elena,Fossa, Paola,Pinna, Gerard A.,Jagerovic, Nadine,Fernández-Ruiz, Javier,Murineddu, Gabriele
, p. 398 - 412 (2017)
In the last few years, cannabinoid type-2 receptor (CB2R) selective ligands have shown a great potential as novel therapeutic drugs in several diseases. With the aim of discovering new selective cannabinoid ligands, a series of pyridazinone-4-c
NOVEL ARYL-CYANOGUANIDINE COMPOUNDS
-
Page/Page column 55, (2016/07/05)
The present invention relates to protein-lysine N-methyltransferase SMYD2 (SET and MYND domain-containing protein 2) inhibitors, in particular SMYD2-inhibitory substituted cyanoguanidine-pyrazolines of general formula (I) wherein R1, R2/s
3-O-Substituted benzyl pyridazinone derivatives as COX inhibitors
Chintakunta, Vamsee Krishna,Akella, Venkateswarlu,Vedula, Manohar Sharma,Mamnoor, Prem Kumar,Mishra, Parimal,Casturi, Seshagiri Rao,Vangoori, Akhila,Rajagopalan, Ramanujam
, p. 339 - 347 (2007/10/03)
New 3-O-substituted benzyl pyridazinone compounds have been synthesised and evaluated for their cyclooxygenase inhibitory activity and COX-2 selectivity. Among the compounds synthesised, three compounds (11b-11d) have shown in vitro COX-2 selectivity. These compounds have been evaluated for their in vivo potential using carrageenan-induced rat paw edema assay. One compound (11b) showed 32% anti-inflammatory activity at 30 mg kg-1 dose.
